These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26470856)

  • 1. Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms.
    Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Schönfeldt-Lecuona C
    J Clin Pharmacol; 2016 Jun; 56(6):769-78. PubMed ID: 26470856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity associated with agomelatine and other antidepressants: Disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring Centre.
    Gahr M; Zeiss R; Lang D; Connemann BJ; Schönfeldt-Lecuona C
    J Clin Pharmacol; 2015 Jul; 55(7):768-73. PubMed ID: 25650773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity related to agomelatine and other new antidepressants: a case/noncase approach with information from the Portuguese, French, Spanish, and Italian pharmacovigilance systems.
    Montastruc F; Scotto S; Vaz IR; Guerra LN; Escudero A; Sáinz M; Falomir T; Bagheri H; Herdeiro MT; Venegoni M; Montastruc JL; Carvajal A
    J Clin Psychopharmacol; 2014 Jun; 34(3):327-30. PubMed ID: 24561328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis.
    Jiang A; Wei C; Zhu W; Wu F; Wu B
    Ther Adv Drug Saf; 2024; 15():20420986241244585. PubMed ID: 38715707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Associated Liver Injury Related to Antipsychotics: Exploratory Analysis of Pharmacovigilance Data.
    Zeiss R; Hafner S; Schönfeldt-Lecuona C; Connemann BJ; Gahr M
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):440-444. PubMed ID: 35730552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone.
    Ye JH; Ho YF; On AW; Chen WW; Huang YM; Huang WI; Tang YW
    Int J Clin Pharm; 2018 Aug; 40(4):911-920. PubMed ID: 30051228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between structural alerts in NSAIDs and idiosyncratic hepatotoxicity: an analysis of spontaneous report data from the WHO database.
    Jessurun N; van Puijenbroek E
    Drug Saf; 2015 May; 38(5):511-5. PubMed ID: 25787329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program.
    Friedrich ME; Akimova E; Huf W; Konstantinidis A; Papageorgiou K; Winkler D; Toto S; Greil W; Grohmann R; Kasper S
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26721950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine and hepatotoxicity: implications of cumulated data derived from spontaneous reports of adverse drug reactions.
    Gahr M; Freudenmann RW; Connemann BJ; Hiemke C; Schönfeldt-Lecuona C
    Pharmacopsychiatry; 2013 Sep; 46(6):214-20. PubMed ID: 23966266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
    Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
    Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
    Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
    BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database.
    Petronijevic M; Ilic K; Suzuki A
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):416-23. PubMed ID: 21370308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic adverse drug reactions: a case/non-case study in Italy.
    Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N
    Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement.
    Gahr M; Connemann BJ; Schönfeldt-Lecuona C; Zeiss R
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28067776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver injury associated with antidepressants.
    Park SH; Ishino R
    Curr Drug Saf; 2013 Jul; 8(3):207-23. PubMed ID: 23914755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-induced liver injury: a review for clinicians.
    Voican CS; Corruble E; Naveau S; Perlemuter G
    Am J Psychiatry; 2014 Apr; 171(4):404-15. PubMed ID: 24362450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance.
    Monaco L; Melis M; Biagi C; Donati M; Sapigni E; Vaccheri A; Motola D
    Expert Opin Drug Saf; 2017 Mar; 16(3):271-275. PubMed ID: 28094583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of agomelatine: focus on hepatotoxicity.
    Gahr M; Kratzer W; Fuchs M; Connemann BJ
    Curr Drug Metab; 2014; 15(7):694-702. PubMed ID: 25255870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation.
    Dupuch M; Grabar N
    J Biomed Inform; 2015 Apr; 54():174-85. PubMed ID: 25659451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.